Free Trial
→ A grave, grave error. (From Porter & Company) (Ad) Buy UHT Stock  Free UHT Stock Alerts

Universal Health Realty Income Trust (UHT) Financials

Universal Health Realty Income Trust logo
$37.92 +0.01 (+0.03%)
Closing price 05/23/2025 03:59 PM Eastern
Extended Trading
$37.94 +0.02 (+0.06%)
As of 05/23/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Universal Health Realty Income Trust

Annual Income Statements for Universal Health Realty Income Trust

This table shows Universal Health Realty Income Trust's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 12/31/2024 12/31/2023 12/31/2022
Net Income / (Loss) Attributable to Common Shareholders		 19 15 21
Consolidated Net Income / (Loss)		 19 15 21
Net Income / (Loss) Continuing Operations		 38 32 32
Total Pre-Tax Income 		37 31 31
Total Revenue		 99 95 91
Net Interest Income / (Expense)		 0.00 0.00 0.00
Total Interest Income		 0.00 0.00 0.00
Total Interest Expense		 0.00 0.00 0.00
Total Non-Interest Income		 99 95 91
Other Service Charges		 2.29 2.50 3.19
Net Realized & Unrealized Capital Gains on Investments		 0.00 -0.23 0.00
Other Non-Interest Income		 97 93 87
Total Non-Interest Expense		 62 64 60
Other Operating Expenses		 35 36 33
Depreciation Expense		 27 28 27
Other Gains / (Losses), net		 1.28 1.21 1.19
Other Adjustments to Consolidated Net Income / (Loss)		 -19 -17 -11
Basic Earnings per Share		 $1.39 $1.12 $1.53
Weighted Average Basic Shares Outstanding		 13.80M 13.79M 13.77M
Diluted Earnings per Share		 $1.39 $1.11 $1.53
Weighted Average Diluted Shares Outstanding		 13.84M 13.81M 13.80M
Weighted Average Basic & Diluted Shares Outstanding		 13.85M 13.82M 13.80M
Cash Dividends to Common per Share		 $2.92 $2.88 $2.84

Quarterly Income Statements for Universal Health Realty Income Trust

This table shows Universal Health Realty Income Trust's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Income / (Loss) Attributable to Common Shareholders		 4.66 4.00 5.28 5.30 3.59 3.87 3.48 4.46 5.63 4.85
Consolidated Net Income / (Loss)		 4.66 4.00 5.28 5.30 3.59 3.87 3.48 4.46 5.63 4.85
Net Income / (Loss) Continuing Operations		 9.58 8.79 9.86 9.85 8.18 8.34 7.65 8.16 14 7.67
Total Pre-Tax Income 		9.26 8.49 9.58 9.46 7.92 8.03 7.38 7.79 8.73 7.32
Total Revenue		 25 24 25 25 24 24 24 23 24 22
Total Non-Interest Income		 25 24 25 25 24 24 24 23 24 22
Other Service Charges		 0.55 0.55 0.56 0.63 0.59 0.66 0.54 0.71 1.76 0.48
Other Non-Interest Income		 24 24 24 25 24 24 23 23 22 22
Total Non-Interest Expense		 15 16 15 16 16 16 16 15 11 15
Other Operating Expenses		 8.59 9.00 8.34 8.87 8.91 9.19 9.57 8.82 4.30 8.17
Depreciation Expense		 6.80 7.01 6.81 6.81 7.25 7.01 6.85 6.62 6.51 6.66
Other Gains / (Losses), net		 0.32 0.30 0.27 0.38 0.25 0.31 0.27 0.37 0.25 0.35
Other Adjustments to Consolidated Net Income / (Loss)		 -4.92 -4.79 -4.58 -4.55 -4.58 -4.47 -4.18 -3.70 - -2.82
Basic Earnings per Share		 $0.34 $0.29 $0.38 $0.38 $0.27 $0.28 $0.25 $0.32 $0.41 $0.35
Weighted Average Basic Shares Outstanding		 13.80M 13.81M 13.80M 13.79M 13.79M 13.79M 13.78M 13.78M 13.77M 13.78M
Diluted Earnings per Share		 $0.34 $0.29 $0.38 $0.38 $0.26 $0.28 $0.25 $0.32 $0.41 $0.35
Weighted Average Diluted Shares Outstanding		 13.84M 13.85M 13.83M 13.82M 13.81M 13.82M 13.81M 13.80M 13.80M 13.80M
Weighted Average Basic & Diluted Shares Outstanding		 13.85M 13.85M 13.85M 13.83M 13.82M 13.82M 13.82M 13.80M 13.80M 13.80M

Annual Cash Flow Statements for Universal Health Realty Income Trust

This table details how cash moves in and out of Universal Health Realty Income Trust's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 12/31/2024 12/31/2023 12/31/2022
Net Change in Cash & Equivalents		 -1.12 0.60 -15
Net Cash From Operating Activities		 47 43 47
Net Cash From Continuing Operating Activities		 47 43 47
Net Income / (Loss) Continuing Operations		 19 15 21
Consolidated Net Income / (Loss)		 19 15 21
Depreciation Expense		 27 28 27
Amortization Expense		 0.59 0.55 0.52
Non-Cash Adjustments to Reconcile Net Income		 0.85 -0.76 0.78
Changes in Operating Assets and Liabilities, net		 -1.19 0.02 -2.16
Net Cash From Investing Activities		 -14 -19 -37
Net Cash From Continuing Investing Activities		 -14 -19 -37
Purchase of Property, Leasehold Improvements and Equipment		 0.00 -7.62 -14
Acquisitions		 0.00 0.00 -1.35
Purchase of Investment Securities		 -5.89 -4.06 -0.09
Sale and/or Maturity of Investments		 0.00 7.39 0.00
Other Investing Activities, net		 -7.98 -15 -22
Net Cash From Financing Activities		 -34 -23 -25
Net Cash From Continuing Financing Activities		 -34 -23 -25
Issuance of Debt		 22 29 26
Issuance of Common Equity		 -0.13 0.15 0.18
Repayment of Debt		 -14 -12 -12
Repurchase of Common Equity		 0.00 0.00 0.00
Payment of Dividends		 -40 -40 -39
Other Financing Activities, Net		 -2.38 -0.22 -0.03
Cash Interest Paid		 18 16 10

Quarterly Cash Flow Statements for Universal Health Realty Income Trust

This table details how cash moves in and out of Universal Health Realty Income Trust's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Change in Cash & Equivalents		 0.73 0.80 -2.12 -0.52 -0.15 -1.10 1.34 0.51 -0.49 -0.30
Net Cash From Operating Activities		 13 9.89 12 12 10 10 12 10 12 9.58
Net Cash From Continuing Operating Activities		 13 9.89 12 12 10 10 12 10 12 9.58
Net Income / (Loss) Continuing Operations		 4.66 4.00 5.28 5.30 3.59 3.87 3.48 4.46 5.63 4.85
Consolidated Net Income / (Loss)		 4.66 4.00 5.28 5.30 3.59 3.87 3.48 4.46 5.63 4.85
Depreciation Expense		 6.80 7.01 6.81 6.81 7.25 7.01 6.85 6.62 6.51 6.66
Amortization Expense		 0.15 0.15 0.15 0.15 0.16 0.14 0.13 0.12 0.13 0.13
Non-Cash Adjustments to Reconcile Net Income		 1.32 -0.88 0.59 -0.18 -1.33 0.81 -0.22 -0.01 1.61 -0.49
Changes in Operating Assets and Liabilities, net		 0.23 -0.38 -0.69 -0.34 0.79 -1.67 2.02 -1.12 -1.59 -1.57
Net Cash From Investing Activities		 -2.71 -1.50 -0.72 -8.95 0.74 -11 -3.48 -5.41 -5.43 -5.44
Net Cash From Continuing Investing Activities		 -2.71 -1.50 -0.72 -8.95 0.74 -11 -3.48 -5.41 -5.43 -5.44
Other Investing Activities, net		 -2.71 -1.50 -0.72 -3.05 -3.14 -3.17 -3.48 -5.04 -5.43 -5.35
Net Cash From Financing Activities		 -9.72 -7.60 -14 -3.31 -11 -0.31 -7.43 -4.15 -7.35 -4.43
Net Cash From Continuing Financing Activities		 -9.72 -7.60 -14 -3.31 -11 -0.31 -7.43 -4.15 -7.35 -4.43
Issuance of Debt		 1.15 4.85 9.25 7.05 5.10 10 3.00 10 8.00 5.80
Issuance of Common Equity		 -0.15 0.03 -0.05 0.04 0.03 0.04 0.04 0.04 0.04 0.04
Repayment of Debt		 -0.32 -0.31 -13 -0.37 -6.47 -0.43 -0.38 -4.61 -5.54 -0.49
Payment of Dividends		 -10 -10 -10 -10 -10.00 -9.93 -9.99 -9.85 -9.85 -9.78
Other Financing Activities, Net		 -0.25 -2.08 -0.02 -0.03 - -0.09 -0.10 -0.03 - -
Cash Interest Paid		 4.77 4.92 4.46 3.76 4.23 4.30 4.01 3.72 3.34 2.72

Annual Balance Sheets for Universal Health Realty Income Trust

This table presents Universal Health Realty Income Trust's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 12/31/2024 12/31/2023 12/31/2022
Total Assets		 581 596 608
Cash and Due from Banks		 7.10 8.21 7.61
Loans and Leases, Net of Allowance		 0.00 0.00 0.00
Premises and Equipment, Net		 437 455 461
Intangible Assets		 7.33 9.11 9.45
Other Assets		 130 124 107
Total Liabilities & Shareholders' Equity		 581 596 608
Total Liabilities		 401 395 378
Non-Interest Bearing Deposits		 11 11 11
Short-Term Debt		 349 327 298
Accrued Interest Payable		 0.69 0.49 0.37
Long-Term Debt		 19 33 45
Other Long-Term Liabilities		 21 24 24
Total Equity & Noncontrolling Interests		 180 201 229
Total Preferred & Common Equity		 180 201 229
Preferred Stock		 0.00 0.00 0.00
Total Common Equity		 180 201 229
Common Stock		 271 271 270
Retained Earnings		 -98 -77 -53
Accumulated Other Comprehensive Income / (Loss)		 6.41 7.31 12

Quarterly Balance Sheets for Universal Health Realty Income Trust

This table presents Universal Health Realty Income Trust's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2024 Q2 2024 Q1 2024 Q3 2023 Q2 2023 Q1 2023 Q3 2022
Period end date 9/30/2024 6/30/2024 3/31/2024 9/30/2023 6/30/2023 3/31/2023 9/30/2022
Total Assets		 584 587 596 608 603 604 609
Cash and Due from Banks		 6.37 5.58 7.70 8.36 9.46 8.12 8.10
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Premises and Equipment, Net		 441 445 450 461 458 459 461
Intangible Assets		 7.76 8.19 8.65 9.65 8.34 8.88 9.94
Other Assets		 129 128 130 107 107 107 107
Total Liabilities & Shareholders' Equity		 584 587 596 608 603 604 609
Total Liabilities		 403 396 400 398 386 382 376
Non-Interest Bearing Deposits		 11 11 11 12 11 11 9.91
Short-Term Debt		 348 343 334 322 311 308 290
Accrued Interest Payable		 0.74 1.02 1.09 0.33 0.34 0.34 0.35
Long-Term Debt		 20 20 33 39 40 40 50
Other Long-Term Liabilities		 24 21 21 25 24 22 25
Total Equity & Noncontrolling Interests		 182 191 196 210 217 222 234
Total Preferred & Common Equity		 182 191 196 210 217 222 234
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 182 191 196 210 217 222 234
Common Stock		 271 271 271 270 270 270 269
Retained Earnings		 -93 -86 -82 -70 -64 -58 -48
Accumulated Other Comprehensive Income / (Loss)		 3.26 6.44 7.50 10 11 10 13

Annual Metrics And Ratios for Universal Health Realty Income Trust

This table displays calculated financial ratios and metrics derived from Universal Health Realty Income Trust's official financial filings.

Metric 2024 2023 2022
Period end date 12/31/2024 12/31/2023 12/31/2022
Growth Metrics		 - - -
Revenue Growth		 3.85% 5.21% 7.64%
EBITDA Growth		 9.11% 2.86% 1.48%
EBIT Growth		 18.25% 1.47% 6.24%
NOPAT Growth		 18.25% 1.47% 6.24%
Net Income Growth		 24.90% -27.02% -80.67%
EPS Growth		 25.23% -27.45% -80.68%
Operating Cash Flow Growth		 9.25% -8.26% -1.93%
Free Cash Flow Firm Growth		 15.84% 86.77% 128.14%
Invested Capital Growth		 -2.25% -2.02% 1.39%
Revenue Q/Q Growth		 0.56% -0.04% 3.09%
EBITDA Q/Q Growth		 1.37% -7.23% 10.56%
EBIT Q/Q Growth		 3.77% -14.78% 23.95%
NOPAT Q/Q Growth		 3.77% -2.53% 4.56%
Net Income Q/Q Growth		 5.88% -11.69% -80.29%
EPS Q/Q Growth		 6.11% -11.90% -80.28%
Operating Cash Flow Q/Q Growth		 6.10% -4.10% 1.65%
Free Cash Flow Firm Q/Q Growth		 -14.14% 22.63% 138.94%
Invested Capital Q/Q Growth		 -0.23% -1.88% -0.36%
Profitability Metrics		 - - -
EBITDA Margin		 65.45% 62.30% 63.72%
EBIT Margin		 37.16% 32.64% 33.84%
Profit (Net Income) Margin		 19.43% 16.15% 23.29%
Tax Burden Percent		 52.27% 49.49% 68.81%
Interest Burden Percent		 100.00% 100.00% 100.00%
Effective Tax Rate		 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 6.64% 5.50% 5.40%
ROIC Less NNEP Spread (ROIC-NNEP)		 1.81% 1.02% 2.55%
Return on Net Nonoperating Assets (RNNOA)		 3.47% 1.67% 3.69%
Return on Equity (ROE)		 10.11% 7.16% 9.09%
Cash Return on Invested Capital (CROIC)		 8.92% 7.53% 4.02%
Operating Return on Assets (OROA)		 6.25% 5.17% 5.09%
Return on Assets (ROA)		 3.27% 2.56% 3.50%
Return on Common Equity (ROCE)		 10.11% 7.16% 9.09%
Return on Equity Simple (ROE_SIMPLE)		 10.71% 7.66% 9.21%
Net Operating Profit after Tax (NOPAT)		 37 31 31
NOPAT Margin		 37.16% 32.64% 33.84%
Net Nonoperating Expense Percent (NNEP)		 4.83% 4.48% 2.85%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 62.84% 67.36% 66.16%
Earnings before Interest and Taxes (EBIT)		 37 31 31
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 65 59 58
Valuation Ratios		 - - -
Price to Book Value (P/BV)		 2.87 2.77 2.51
Price to Tangible Book Value (P/TBV)		 2.99 2.90 2.62
Price to Revenue (P/Rev)		 5.20 5.83 6.35
Price to Earnings (P/E)		 26.79 36.09 27.29
Dividend Yield		 7.85% 7.16% 6.81%
Earnings Yield		 3.73% 2.77% 3.66%
Enterprise Value to Invested Capital (EV/IC)		 1.60 1.62 1.59
Enterprise Value to Revenue (EV/Rev)		 8.85 9.51 10.05
Enterprise Value to EBITDA (EV/EBITDA)		 13.52 15.27 15.78
Enterprise Value to EBIT (EV/EBIT)		 23.82 29.15 29.71
Enterprise Value to NOPAT (EV/NOPAT)		 23.82 29.15 29.71
Enterprise Value to Operating Cash Flow (EV/OCF)		 18.68 21.12 19.46
Enterprise Value to Free Cash Flow (EV/FCFF)		 17.74 21.27 39.90
Leverage & Solvency		 - - -
Debt to Equity		 2.05 1.79 1.50
Long-Term Debt to Equity		 0.11 0.16 0.20
Financial Leverage		 1.91 1.63 1.45
Leverage Ratio		 3.09 2.80 2.60
Compound Leverage Factor		 3.09 2.80 2.60
Debt to Total Capital		 67.22% 64.14% 59.94%
Short-Term Debt to Total Capital		 63.69% 58.28% 52.12%
Long-Term Debt to Total Capital		 3.53% 5.86% 7.82%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00%
Common Equity to Total Capital		 32.78% 35.86% 40.06%
Debt to EBITDA		 5.68 6.05 5.94
Net Debt to EBITDA		 5.57 5.91 5.81
Long-Term Debt to EBITDA		 0.30 0.55 0.77
Debt to NOPAT		 10.01 11.55 11.18
Net Debt to NOPAT		 9.82 11.29 10.93
Long-Term Debt to NOPAT		 0.53 1.06 1.46
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00%
Liquidity Ratios		 - - -
Cash Flow Metrics		 - - -
Free Cash Flow to Firm (FCFF)		 49 43 23
Operating Cash Flow to CapEx		 0.00% 563.50% 343.65%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00
Efficiency Ratios		 - - -
Asset Turnover		 0.17 0.16 0.15
Fixed Asset Turnover		 0.22 0.21 0.20
Capital & Investment Metrics		 - - -
Invested Capital		 548 560 572
Invested Capital Turnover		 0.18 0.17 0.16
Increase / (Decrease) in Invested Capital		 -13 -12 7.83
Enterprise Value (EV)		 876 907 911
Market Capitalization		 515 556 576
Book Value per Share		 $12.96 $14.54 $16.60
Tangible Book Value per Share		 $12.43 $13.88 $15.91
Total Capital		 548 560 572
Total Debt		 368 359 343
Total Long-Term Debt		 19 33 45
Net Debt		 361 351 335
Capital Expenditures (CapEx)		 0.00 7.62 14
Net Nonoperating Expense (NNE)		 18 16 9.56
Net Nonoperating Obligations (NNO)		 368 359 343
Total Depreciation and Amortization (D&A)		 28 28 27
Earnings Adjustments		 - - -
Adjusted Basic Earnings per Share		 $1.39 $1.12 $1.53
Adjusted Weighted Average Basic Shares Outstanding		 13.80M 13.79M 13.77M
Adjusted Diluted Earnings per Share		 $1.39 $1.11 $1.53
Adjusted Weighted Average Diluted Shares Outstanding		 13.84M 13.81M 13.80M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 13.85M 13.82M 13.80M
Normalized Net Operating Profit after Tax (NOPAT)		 26 22 21
Normalized NOPAT Margin		 26.01% 22.85% 23.69%
Pre Tax Income Margin		 37.16% 32.64% 33.84%
Debt Service Ratios		 - - -
EBIT to Interest Expense		 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00
Payout Ratios		 - - -
Dividend Payout Ratio		 210.01% 258.21% 185.66%
Augmented Payout Ratio		 210.01% 258.21% 185.66%

Quarterly Metrics And Ratios for Universal Health Realty Income Trust

This table displays calculated financial ratios and metrics derived from Universal Health Realty Income Trust's official financial filings.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 2.30% 1.12% 3.90% 8.25% -0.17% 9.35% 7.37% 4.74% 12.70% 4.46%
EBITDA Growth		 5.69% 3.08% 15.14% 13.06% -23.19% 7.59% 22.88% 21.16% 38.19% -0.79%
EBIT Growth		 16.86% 5.79% 29.79% 21.55% -40.51% 9.62% 51.53% 51.08% 80.16% 0.41%
NOPAT Growth		 16.86% 5.79% 29.79% 21.55% -9.24% 9.62% 1.99% 5.56% 18.08% 0.41%
Net Income Growth		 29.72% 3.23% 51.78% 18.86% -36.19% -20.13% -33.38% -17.50% -93.85% -9.28%
EPS Growth		 30.77% 3.57% 52.00% 18.75% -36.59% -20.00% -34.21% -17.95% -93.83% -10.26%
Operating Cash Flow Growth		 25.81% -2.65% -1.04% 16.59% -14.92% 6.12% -7.42% -13.98% 6.57% -11.32%
Free Cash Flow Firm Growth		 12.41% 181.04% 156.26% 217.95% 2,068.56% 113.49% 110.20% 105.73% 100.87% -170.31%
Invested Capital Growth		 -2.25% -3.87% -2.50% -1.42% -2.02% -0.50% -0.33% 0.40% 1.39% 18.10%
Revenue Q/Q Growth		 0.60% -0.97% -1.62% 4.37% -0.56% 1.75% 2.50% -3.74% 8.93% -0.09%
EBITDA Q/Q Growth		 3.58% -5.39% 0.72% 7.09% 1.01% 5.67% -1.10% -27.24% 41.50% 20.69%
EBIT Q/Q Growth		 9.06% -11.41% 1.28% 19.44% -1.27% 8.68% -5.15% -41.55% 81.93% 50.24%
NOPAT Q/Q Growth		 9.06% -11.41% 1.28% 19.44% -1.27% 8.68% -5.15% -10.82% 19.25% 1.12%
Net Income Q/Q Growth		 16.61% -24.24% -0.45% 47.51% -7.21% 11.39% -22.05% -20.81% 16.15% -7.09%
EPS Q/Q Growth		 17.24% -23.68% 0.00% 46.15% -7.14% 12.00% -21.88% -21.95% 17.14% -7.89%
Operating Cash Flow Q/Q Growth		 32.95% -18.42% 3.31% 12.27% 2.88% -17.07% 21.71% -18.07% 28.33% -27.65%
Free Cash Flow Firm Q/Q Growth		 -28.46% 28.49% 35.64% -9.84% 78.85% 17.16% 68.29% 514.94% 101.11% 11.34%
Invested Capital Q/Q Growth		 -0.23% -0.82% -1.61% 0.40% -1.88% 0.59% -0.51% -0.22% -0.36% 0.76%
Profitability Metrics		 - - - - - - - - - -
EBITDA Margin		 65.76% 63.87% 66.86% 65.31% 63.65% 62.66% 60.33% 62.53% 82.73% 63.69%
EBIT Margin		 37.57% 34.66% 38.75% 37.64% 32.89% 33.13% 31.02% 33.52% 55.20% 33.05%
Profit (Net Income) Margin		 18.91% 16.32% 21.33% 21.08% 14.92% 15.98% 14.60% 19.20% 23.34% 21.89%
Tax Burden Percent		 50.34% 47.08% 55.05% 56.01% 45.35% 48.25% 47.07% 57.28% 64.50% 66.22%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 65.55% 100.00%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 6.71% 6.09% 6.79% 6.46% 5.54% 5.52% 5.09% 5.40% 5.77% 5.48%
ROIC Less NNEP Spread (ROIC-NNEP)		 5.45% 4.86% 5.58% 5.30% 4.31% 4.33% 3.95% 4.42% 4.85% 4.75%
Return on Net Nonoperating Assets (RNNOA)		 10.42% 9.03% 9.78% 9.04% 7.03% 6.85% 6.01% 6.54% 7.01% 8.31%
Return on Equity (ROE)		 17.14% 15.12% 16.56% 15.50% 12.57% 12.37% 11.09% 11.94% 12.79% 13.79%
Cash Return on Invested Capital (CROIC)		 8.92% 10.27% 8.78% 7.21% 7.53% 6.07% 5.82% 5.06% 4.02% -11.06%
Operating Return on Assets (OROA)		 6.32% 5.72% 6.40% 6.10% 5.21% 5.19% 4.80% 5.09% 8.30% 5.16%
Return on Assets (ROA)		 3.18% 2.70% 3.52% 3.42% 2.36% 2.51% 2.26% 2.92% 3.51% 3.41%
Return on Common Equity (ROCE)		 17.14% 15.12% 16.56% 15.50% 12.57% 12.37% 11.09% 11.94% 12.79% 13.79%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 10.00% 9.46% 8.27% 0.00% 8.29% 8.50% 9.07% 0.00% 45.84%
Net Operating Profit after Tax (NOPAT)		 9.26 8.49 9.58 9.46 7.92 8.03 7.38 7.79 8.73 7.32
NOPAT Margin		 37.57% 34.66% 38.75% 37.64% 32.89% 33.13% 31.02% 33.52% 36.18% 33.05%
Net Nonoperating Expense Percent (NNEP)		 1.26% 1.23% 1.21% 1.17% 1.23% 1.18% 1.14% 0.98% 0.92% 0.73%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 62.43% 65.34% 61.25% 62.36% 67.11% 66.87% 68.98% 66.48% 44.80% 66.95%
Earnings before Interest and Taxes (EBIT)		 9.26 8.49 9.58 9.46 7.92 8.03 7.38 7.79 13 7.32
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 16 16 17 16 15 15 14 15 20 14
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 2.87 3.49 2.84 2.53 2.77 2.48 2.82 2.74 2.51 2.28
Price to Tangible Book Value (P/TBV)		 2.99 3.64 2.96 2.65 2.90 2.59 2.94 2.86 2.62 2.38
Price to Revenue (P/Rev)		 5.20 6.44 5.51 5.12 5.83 5.46 6.56 6.65 6.35 6.05
Price to Earnings (P/E)		 26.79 34.88 29.99 30.66 36.09 29.86 33.22 30.24 27.29 4.97
Dividend Yield		 7.85% 6.36% 7.41% 8.02% 7.16% 7.62% 6.45% 6.45% 6.81% 7.34%
Earnings Yield		 3.73% 2.87% 3.33% 3.26% 2.77% 3.35% 3.01% 3.31% 3.66% 20.13%
Enterprise Value to Invested Capital (EV/IC)		 1.60 1.81 1.62 1.52 1.62 1.53 1.68 1.66 1.59 1.51
Enterprise Value to Revenue (EV/Rev)		 8.85 10.10 9.15 8.80 9.51 9.15 10.22 10.36 10.05 9.83
Enterprise Value to EBITDA (EV/EBITDA)		 13.52 15.56 14.16 13.97 15.27 13.64 15.14 15.76 15.78 16.55
Enterprise Value to EBIT (EV/EBIT)		 23.82 28.05 25.67 26.11 29.15 23.91 26.62 28.53 29.71 34.93
Enterprise Value to NOPAT (EV/NOPAT)		 23.82 28.05 25.67 26.11 29.15 27.35 30.54 30.57 29.71 29.46
Enterprise Value to Operating Cash Flow (EV/OCF)		 18.68 22.50 20.20 19.20 21.12 19.50 21.58 21.03 19.46 18.77
Enterprise Value to Free Cash Flow (EV/FCFF)		 17.74 17.29 18.26 20.95 21.27 25.11 28.79 32.97 39.90 0.00
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 2.05 2.02 1.90 1.86 1.79 1.72 1.62 1.57 1.50 1.46
Long-Term Debt to Equity		 0.11 0.11 0.10 0.17 0.16 0.19 0.18 0.18 0.20 0.22
Financial Leverage		 1.91 1.86 1.75 1.71 1.63 1.58 1.52 1.48 1.45 1.75
Leverage Ratio		 3.09 3.04 2.92 2.87 2.80 2.74 2.67 2.63 2.60 2.92
Compound Leverage Factor		 3.09 3.04 2.92 2.87 2.80 2.74 2.67 2.63 1.70 2.92
Debt to Total Capital		 67.22% 66.92% 65.55% 65.08% 64.14% 63.18% 61.85% 61.07% 59.94% 59.30%
Short-Term Debt to Total Capital		 63.69% 63.34% 61.94% 59.30% 58.28% 56.29% 54.85% 54.04% 52.12% 50.54%
Long-Term Debt to Total Capital		 3.53% 3.58% 3.61% 5.78% 5.86% 6.88% 7.00% 7.03% 7.82% 8.75%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 32.78% 33.08% 34.45% 34.92% 35.86% 36.82% 38.16% 38.93% 40.06% 40.70%
Debt to EBITDA		 5.68 5.75 5.72 5.97 6.05 5.64 5.58 5.78 5.94 6.52
Net Debt to EBITDA		 5.57 5.65 5.63 5.85 5.91 5.51 5.43 5.65 5.81 6.36
Long-Term Debt to EBITDA		 0.30 0.31 0.31 0.53 0.55 0.61 0.63 0.67 0.77 0.96
Debt to NOPAT		 10.01 10.36 10.37 11.17 11.55 11.30 11.25 11.22 11.18 11.60
Net Debt to NOPAT		 9.82 10.18 10.21 10.93 11.29 11.04 10.94 10.95 10.93 11.33
Long-Term Debt to NOPAT		 0.53 0.55 0.57 0.99 1.06 1.23 1.27 1.29 1.46 1.71
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 22 31 24 18 19 11 9.28 5.52 0.90 -81
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00% 47,522.73% 133.75% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 0.17 0.17 0.17 0.16 0.16 0.16 0.15 0.15 0.15 0.16
Fixed Asset Turnover		 0.22 0.22 0.22 0.21 0.21 0.21 0.20 0.20 0.20 0.19
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 548 549 554 563 560 571 568 571 572 574
Invested Capital Turnover		 0.18 0.18 0.18 0.17 0.17 0.17 0.16 0.16 0.16 0.17
Increase / (Decrease) in Invested Capital		 -13 -22 -14 -8.08 -12 -2.85 -1.90 2.27 7.83 88
Enterprise Value (EV)		 876 995 898 856 907 873 953 950 911 864
Market Capitalization		 515 634 541 498 556 521 612 609 576 532
Book Value per Share		 $12.96 $13.12 $13.79 $14.24 $14.54 $15.22 $15.69 $16.10 $16.60 $16.93
Tangible Book Value per Share		 $12.43 $12.56 $13.20 $13.62 $13.88 $14.52 $15.09 $15.45 $15.91 $16.21
Total Capital		 548 549 554 563 560 571 568 571 572 574
Total Debt		 368 367 363 366 359 361 351 349 343 340
Total Long-Term Debt		 19 20 20 33 33 39 40 40 45 50
Net Debt		 361 361 357 358 351 352 342 340 335 332
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.00 0.02 7.60 0.00 0.00 0.00 0.00
Net Nonoperating Expense (NNE)		 4.60 4.49 4.31 4.16 4.33 4.15 3.91 3.33 3.10 2.47
Net Nonoperating Obligations (NNO)		 368 367 363 366 359 361 351 349 343 340
Total Depreciation and Amortization (D&A)		 6.95 7.16 6.95 6.96 7.41 7.15 6.98 6.74 6.64 6.79
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.34 $0.29 $0.38 $0.38 $0.27 $0.28 $0.25 $0.32 $0.41 $0.35
Adjusted Weighted Average Basic Shares Outstanding		 13.80M 13.81M 13.80M 13.79M 13.79M 13.79M 13.78M 13.78M 13.77M 13.78M
Adjusted Diluted Earnings per Share		 $0.34 $0.29 $0.38 $0.38 $0.26 $0.28 $0.25 $0.32 $0.41 $0.35
Adjusted Weighted Average Diluted Shares Outstanding		 13.84M 13.85M 13.83M 13.82M 13.81M 13.82M 13.81M 13.80M 13.80M 13.80M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 13.85M 13.85M 13.85M 13.83M 13.82M 13.82M 13.82M 13.80M 13.80M 13.80M
Normalized Net Operating Profit after Tax (NOPAT)		 6.48 5.94 6.71 6.62 5.55 5.62 5.17 5.45 6.11 5.12
Normalized NOPAT Margin		 26.30% 24.26% 27.12% 26.35% 23.02% 23.19% 21.71% 23.46% 25.33% 23.14%
Pre Tax Income Margin		 37.57% 34.66% 38.75% 37.64% 32.89% 33.13% 31.02% 33.52% 36.18% 33.05%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 210.01% 221.51% 222.18% 245.76% 258.21% 227.19% 214.34% 195.10% 185.66% 36.45%
Augmented Payout Ratio		 210.01% 221.51% 222.18% 245.76% 258.21% 227.19% 214.34% 195.10% 185.66% 36.45%

Frequently Asked Questions About Universal Health Realty Income Trust's Financials

When does Universal Health Realty Income Trust's fiscal year end?

According to the most recent income statement we have on file, Universal Health Realty Income Trust's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Universal Health Realty Income Trust's net income changed over the last 2 years?

Universal Health Realty Income Trust's net income appears to be on a downward trend, with a most recent value of $19.23 million in 2024, falling from $21.10 million in 2022. The previous period was $15.40 million in 2023.

How has Universal Health Realty Income Trust revenue changed over the last 2 years?

Over the last 2 years, Universal Health Realty Income Trust's total revenue changed from $90.63 million in 2022 to $99.01 million in 2024, a change of 9.3%.

How much debt does Universal Health Realty Income Trust have?

Universal Health Realty Income Trust's total liabilities were at $401.32 million at the end of 2024, a 1.5% increase from 2023, and a 6.0% increase since 2022.

How much cash does Universal Health Realty Income Trust have?

In the past 2 years, Universal Health Realty Income Trust's cash and equivalents has ranged from $7.10 million in 2024 to $8.21 million in 2023, and is currently $7.10 million as of their latest financial filing in 2024.

How has Universal Health Realty Income Trust's book value per share changed over the last 2 years?

Over the last 2 years, Universal Health Realty Income Trust's book value per share changed from 16.60 in 2022 to 12.96 in 2024, a change of -21.9%.


Related Companies

This page (NYSE:UHT) was last updated on 5/25/2025 by MarketBeat.com Staff
From Our Partners
Gold Hits New Highs as Global Markets Spiral
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...
Premier Gold Co | Sponsored
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored
Buffett’s favorite chart just hit 209% – here’s what that means for gold
A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...
Golden Portfolio | Sponsored
Is President Trump Lying To You With This?
President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...
Colonial Metals | Sponsored
A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...
Porter & Company | Sponsored
Trump’s Bitcoin Reserve is No Accident…
Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...
Crypto 101 Media | Sponsored
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...
Crypto Swap Profits | Sponsored
Massive new energy source found in Utah
NEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...
Stansberry Research | Sponsored